AcelRx Pharmaceuticals, Inc. (ACRX) Earnings
|
Expand Research on ACRX
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -425.9% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | N/A |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/8/23 | Q323 | -$0.08 | -$0.28 | +$0.20 | $120K | $130K | N/A | Details | |||
11/10/22 | Q322 | N/A | -$0.07 | N/A | N/A | $775K | N/A | N/A | N/A | ||
8/11/22 | Q222 | -$0.08 | -$0.08 | $0.00 | $443K | $550K | N/A | Details | |||
5/16/22 | Q122 | -$0.06 | -$0.06 | $0.00 | $442K | $550K | N/A | Details | |||
5/10/23 | Q122 | -$0.75 | -$0.04 | -$0.71 | N/A | $5.35M | N/A | Details | |||
3/10/22 | Q421 | -$0.06 | $0.00 | -$0.06 | N/A | $1.85M | N/A | Details | |||
11/15/21 | Q321 | -$0.07 | -$0.07 | $0.00 | $1.86M | $1.9M | N/A | Details | |||
8/16/21 | Q221 | -$0.08 | -$0.08 | $0.00 | $400K | $1.81M | N/A | Details |